What is EvolvedPeptides?

A high-performance platform for tracking and optimizing peptide research and wellness data.

How do Tesamorelin and CJC 1295 differ in mechanism?

Tesamorelin: Full 44-amino acid GHRH analogue that stimulates pulsatile pituitary GH release, driving lipolysis preferentially in visceral adipose tissue. CJC 1295: GHRH analogue (29 amino acids) that binds pituitary GHRH receptors to expand the releasable GH pool. Without DAC it produces a sharp physiological pulse; with DAC it binds albumin for a 6–8 day half-life.

What research concentrations are referenced for Tesamorelin and CJC 1295?

Tesamorelin is catalogued at 10mg. CJC 1295 is catalogued at 10mg. Concentrations and reconstitution volumes are documented on each product page for laboratory reference.

Are Tesamorelin and CJC 1295 sold for human use?

No. Tesamorelin and CJC 1295 are sold strictly for in vitro laboratory research use. They are not for human consumption, medical use, or self-administration, and they have not been evaluated by the FDA.

Where can I read the published research on Tesamorelin and CJC 1295?

Peer-reviewed literature for both compounds is indexed on PubMed, and selected studies are linked on this page and on each product page. All references are provided for research and informational purposes only.

Tesamorelin vs CJC 1295

A side-by-side research reference for Tesamorelin and CJC 1295 — mechanism of action, catalogue data, and the key studies behind each compound.

Comparison	Tesamorelin $50.00 Shop Tesamorelin	CJC 1295 $45.00 Shop CJC 1295
Compound class	Peptides · Injectable vial	Peptides · Injectable vial
Mechanism of action	Full 44-amino acid GHRH analogue that stimulates pulsatile pituitary GH release, driving lipolysis preferentially in visceral adipose tissue.	GHRH analogue (29 amino acids) that binds pituitary GHRH receptors to expand the releasable GH pool. Without DAC it produces a sharp physiological pulse; with DAC it binds albumin for a 6–8 day half-life.
Reference concentration	10mg	10mg
Research form	Injectable vial	Injectable vial

Key studies on Tesamorelin

Tesamorelin growth hormone-releasing hormone analog reduces visceral adiposity (NEJM)Tesamorelin improves body composition in HIV-associated lipodystrophy GHRH analog tesamorelin enhances GH/IGF-1 axis and metabolic profile

Key studies on CJC 1295

Published literature for this compound is indexed on PubMed.

Shop

Tesamorelin 10mg

$50.00

Shop

CJC-1295 10mg (With DAC)

$45.00

More comparisons

Semaglutide vs Tirzepatide CJC 1295 vs Ipamorelin Semax vs Selank Retatrutide vs Tirzepatide PT 141 vs Melanotan 2 GHK Cu vs Epithalon

Research Use Only

All compounds referenced on this page are sold for in vitro laboratory research use only. Not for human consumption, medical use, or self-administration. Not evaluated by the FDA. This page is for research and informational purposes only.